Widely read:
Gland Pharma was the pharma star of 2020. After listing at a premium of 21 per cent over its issue price, it delivered blockbuster returns of 137 per cent in the seven months that followed.
Recently Viewed
Clear AllWe look at why the pharma stock is limping after an initial rally in 2020
Last updated: 06-Sep-2023•Udhayaprakash
Gland Pharma was the pharma star of 2020. After listing at a premium of 21 per cent over its issue price, it delivered blockbuster returns of 137 per cent in the seven months that followed.
Your fund made 18%. You made 8%
4 min read•By Pranit Mathur
New episodes every Friday
The gambling instinct
When investing morphs into betting, everyone loses except the house
Other Episodes
Winning by doing nothing
Market turmoil from tariff wars offers a masterclass in investor psychology
Gems in the rubble
Quality small caps stand tall in this market downturn
Invert to succeed
Charlie Munger's mental tricks offer powerful investing wisdom
Compounding is more than maths
Rigid definitions can limit our understanding of how wealth grows
8 stocks to watch today - April 23, 2025
3 min read•By Bazaar Bhardwaj
Our rating system has guided millions of investors in the past 20 years.
